Literature DB >> 27320471

Community Health Workers as Support for Sickle Cell Care.

Lewis L Hsu1, Nancy S Green2, E Donnell Ivy3, Cindy E Neunert4, Arlene Smaldone4, Shirley Johnson5, Sheila Castillo1, Amparo Castillo1, Trevor Thompson6, Kisha Hampton7, John J Strouse8, Rosalyn Stewart8, TaLana Hughes9, Sonja Banks10, Kim Smith-Whitley11, Allison King12, Mary Brown13, Kwaku Ohene-Frempong11, Wally R Smith5, Molly Martin1.   

Abstract

Community health workers are increasingly recognized as useful for improving health care and health outcomes for a variety of chronic conditions. Community health workers can provide social support, navigation of health systems and resources, and lay counseling. Social and cultural alignment of community health workers with the population they serve is an important aspect of community health worker intervention. Although community health worker interventions have been shown to improve patient-centered outcomes in underserved communities, these interventions have not been evaluated with sickle cell disease. Evidence from other disease areas suggests that community health worker intervention also would be effective for these patients. Sickle cell disease is complex, with a range of barriers to multifaceted care needs at the individual, family/friend, clinical organization, and community levels. Care delivery is complicated by disparities in health care: access, delivery, services, and cultural mismatches between providers and families. Current practices inadequately address or provide incomplete control of symptoms, especially pain, resulting in decreased quality of life and high medical expense. The authors propose that care and care outcomes for people with sickle cell disease could be improved through community health worker case management, social support, and health system navigation. This paper outlines implementation strategies in current use to test community health workers for sickle cell disease management in a variety of settings. National medical and advocacy efforts to develop the community health workforce for sickle cell disease management may enhance the progress and development of "best practices" for this area of community-based care.
Copyright © 2016 American Journal of Preventive Medicine. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27320471      PMCID: PMC4918511          DOI: 10.1016/j.amepre.2016.01.016

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  88 in total

Review 1.  Designing and evaluating interventions to eliminate racial and ethnic disparities in health care.

Authors:  Lisa A Cooper; Martha N Hill; Neil R Powe
Journal:  J Gen Intern Med       Date:  2002-06       Impact factor: 5.128

Review 2.  Sickle cell disease related pain: crisis and conflict.

Authors:  Knox H Todd; Carmen Green; Vence L Bonham; Carlton Haywood; Evera Ivy
Journal:  J Pain       Date:  2006-07       Impact factor: 5.820

3.  Social networks and social support: implications for natural helper and community level interventions.

Authors:  B A Israel
Journal:  Health Educ Q       Date:  1985

4.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

5.  Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium.

Authors:  Carlton Dampier; Petra LeBeau; Seungshin Rhee; Susan Lieff; Karen Kesler; Samir Ballas; Zora Rogers; Winfred Wang
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

Review 6.  Systematic review of U.S.-based randomized controlled trials using community health workers.

Authors:  M Christopher Gibbons; Nadra C Tyus
Journal:  Prog Community Health Partnersh       Date:  2007

Review 7.  Lay health workers in primary and community health care.

Authors:  S A Lewin; J Dick; P Pond; M Zwarenstein; G Aja; B van Wyk; X Bosch-Capblanch; M Patrick
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

8.  Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States.

Authors:  Mercy Mvundura; Djesika Amendah; Patricia L Kavanagh; Philippa G Sprinz; Scott D Grosse
Journal:  Pediatr Blood Cancer       Date:  2009-10       Impact factor: 3.167

9.  Primary Care Providers' Comfort Levels in Caring for Patients with Sickle Cell Disease.

Authors:  Lauren N Whiteman; Carlton Haywood; Sophie Lanzkron; John J Strouse; Leonard Feldman; Rosalyn W Stewart
Journal:  South Med J       Date:  2015-09       Impact factor: 0.954

10.  The proportion of potentially preventable emergency department visits by patients with sickle cell disease.

Authors:  Mark Nimmer; Raymond G Hoffmann; Mahua Dasgupta; Julie Panepinto; David C Brousseau
Journal:  J Pediatr Hematol Oncol       Date:  2015-01       Impact factor: 1.289

View more
  20 in total

1.  Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.

Authors:  Arlene Smaldone; Sally Findley; Suzanne Bakken; L Adriana Matiz; Susan L Rosenthal; Haomiao Jia; Sergio Matos; Deepa Manwani; Nancy S Green
Journal:  Contemp Clin Trials       Date:  2016-06-17       Impact factor: 2.226

2.  HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease.

Authors:  Arlene Smaldone; Sally Findley; Deepa Manwani; Haomiao Jia; Nancy S Green
Journal:  J Pediatr       Date:  2018-03-20       Impact factor: 4.406

3.  Unpacking the 'black box' of lay health worker processes in a US-based intervention.

Authors:  Nancy J Burke; Kristine Phung; Filmer Yu; Ching Wong; Khanh Le; Isabel Nguyen; Long Nguyen; Alice Guan; Tung T Nguyen; Janice Y Tsoh
Journal:  Health Promot Int       Date:  2020-02-01       Impact factor: 2.483

Review 4.  Reducing Health Care Disparities in Sickle Cell Disease: A Review.

Authors:  LaTasha Lee; Kim Smith-Whitley; Sonja Banks; Gary Puckrein
Journal:  Public Health Rep       Date:  2019-10-10       Impact factor: 2.792

5.  Barriers and Facilitators to Chronic Red Cell Transfusion Therapy in Pediatric Sickle Cell Anemia.

Authors:  Alyssa M Schlenz; Shannon M Phillips; Martina Mueller; Cathy L Melvin; Robert J Adams; Julie Kanter
Journal:  J Pediatr Hematol Oncol Nurs       Date:  2022-03-14

6.  Persistently Frequent Emergency Department Utilization Among Persons With Systemic Lupus Erythematosus.

Authors:  Jiha Lee; Judith Lin; Lisa Gale Suter; Liana Fraenkel
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-10-16       Impact factor: 4.794

7.  Maintenance of a High Influenza Vaccination Rate and Improvement in Health Outcomes in a Pediatric Sickle Cell Disease Clinic.

Authors:  Zachary C Lo; Amy E Sobota
Journal:  J Pediatr Hematol Oncol       Date:  2022-01-01       Impact factor: 1.170

8.  Paediatric patient navigation models of care in Canada: An environmental scan.

Authors:  Alison Luke; Shelley Doucet; Rima Azar
Journal:  Paediatr Child Health       Date:  2018-01-02       Impact factor: 2.253

9.  Safeguarding children and young people requiring kidney replacement therapy: challenges and potential opportunities.

Authors:  Hannah Jacob; Matko Marlais
Journal:  Pediatr Nephrol       Date:  2021-07-10       Impact factor: 3.714

10.  The influence of perceived racial bias and health-related stigma on quality of life among children with sickle cell disease.

Authors:  Anna M Hood; Lori E Crosby; Eva Hanson; Lisa M Shook; Jeffrey D Lebensburger; Avi Madan-Swain; Megan M Miller; Zina Trost
Journal:  Ethn Health       Date:  2020-09-08       Impact factor: 2.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.